BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12228321)

  • 1. A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.
    Zhang Z; Duchêne M; Stanley SL
    Infect Immun; 2002 Oct; 70(10):5873-6. PubMed ID: 12228321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.
    Marinets A; Zhang T; Guillén N; Gounon P; Bohle B; Vollmann U; Scheiner O; Wiedermann G; Stanley SL; Duchêne M
    J Exp Med; 1997 Nov; 186(9):1557-65. PubMed ID: 9348313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells.
    Carrero JC; Díaz MY; Viveros M; Espinoza B; Acosta E; Ortiz-Ortiz L
    Infect Immun; 1994 Feb; 62(2):764-7. PubMed ID: 8300242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of adhesion by monoclonal antibody to 66 kDa surface antigen of Entamoeba histolytica.
    Vohra H; Kaur S; Ganguly NK; Mahajan RC
    Arch Med Res; 1992; 23(2):235-7. PubMed ID: 1340302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease.
    Zhang Z; Mahajan S; Zhang X; Stanley SL
    Infect Immun; 2003 Sep; 71(9):5355-9. PubMed ID: 12933883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice.
    Zhang T; Cieslak PR; Foster L; Kunz-Jenkins C; Stanley SL
    Parasite Immunol; 1994 May; 16(5):225-30. PubMed ID: 8072766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis.
    Seydel KB; Li E; Swanson PE; Stanley SL
    Infect Immun; 1997 May; 65(5):1631-9. PubMed ID: 9125540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides.
    Melzer H; Baier K; Felici F; von Specht BU; Wiedermann G; Kollaritsch H; Wiedermann U; Duchêne M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):179-83. PubMed ID: 12832123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mucosal secretory immunity in the development of an amebiasis vaccine.
    Ravdin JI; Kelsall BL
    Am J Trop Med Hyg; 1994; 50(5 Suppl):36-41. PubMed ID: 8203722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
    Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
    Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of amoebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis.
    Zhang X; Zhang Z; Alexander D; Bracha R; Mirelman D; Stanley SL
    Infect Immun; 2004 Feb; 72(2):678-83. PubMed ID: 14742508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.
    Cobo ER; He C; Hirata K; Hwang G; Tran U; Eckmann L; Gallo RL; Reed SL
    Infect Immun; 2012 Jan; 80(1):143-9. PubMed ID: 22083705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of heparan sulphate binding proteins of Entamoeba histolytica in a guinea pig model of intestinal amoebiasis.
    Kaur U; Khurana S; Saikia UN; Dubey ML
    Exp Parasitol; 2013 Nov; 135(3):486-96. PubMed ID: 24007700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies.
    Seydel KB; Braun KL; Zhang T; Jackson TF; Stanley SL
    Am J Trop Med Hyg; 1996 Sep; 55(3):330-2. PubMed ID: 8842124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica.
    Melzer H; Fortugno P; Mansouri E; Felici F; Marinets A; Wiedermann G; Kollaritsch H; Von Specht BU; Duchêne M
    Parasite Immunol; 2002 Jun; 24(6):321-8. PubMed ID: 12102717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
    Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
    Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new isoform of the serine-rich E. histolytica protein recognized by human secretory IgA antibodies from patients with intestinal amebiasis.
    Carrero JC; Petrossian P; Sánchez-Zerpa M; Laclette JP; Ortiz-Ortiz L
    Arch Med Res; 1997; 28 Spec No():259-61. PubMed ID: 9033093
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay.
    Gonzalez-Ruiz A; Haque R; Rehman T; Aguirre A; Hall A; Guhl F; Warhurst DC; Miles MA
    J Clin Microbiol; 1994 Apr; 32(4):964-70. PubMed ID: 8027351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further diagnostic use of an invasive-specific monoclonal antibody against Entamoeba histolytica.
    González-Ruíz A; Haque R; Rehman T; Aguirre A; Castañón G; Hall A; Guhl F; Ruíz-Palacios G; Warhurst DC; Miles MA
    Arch Med Res; 1992; 23(2):281-3. PubMed ID: 1340315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
    Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
    Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.